Clinical response: intent-to-treat patients (N = 30)
| NHL response criteria . | CR N (%) . | CRu N (%) . | PR N (%) . | ORR N (%) . | 95% CI ORR . |
|---|---|---|---|---|---|
| International Workshop | 11 (37) | 2 (6.7) | 12 (40) | 25 (83) | 64.5%-93.7% |
| Study protocol–defined* | 10 (33) | N/A | 10 (33) | 20 (67) | 48.1%-85.2% |
| NHL response criteria . | CR N (%) . | CRu N (%) . | PR N (%) . | ORR N (%) . | 95% CI ORR . |
|---|---|---|---|---|---|
| International Workshop | 11 (37) | 2 (6.7) | 12 (40) | 25 (83) | 64.5%-93.7% |
| Study protocol–defined* | 10 (33) | N/A | 10 (33) | 20 (67) | 48.1%-85.2% |
NHL indicates non-Hodgkin lymphoma; CR, complete response; CRu, complete response unconfirmed; PR, partial response; ORR, overall response rate; CI, confidence interval; and NA, not applicable.
No patients were classified as CCR.